AVITA Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
AVITA Medical filed this Form 8-K on December 8, 2021, under Item 8.01 (Other Events). The filing clarifies board and committee meeting attendance during the fiscal year ended June 30, 2021.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Material Changes Versus Prior Period
The filing reports no financial or operational change. It provides a governance clarification regarding meeting frequency and director attendance.
- The Board of Directors met nine times during fiscal 2021.
- Each director attended at least 75% of Board meetings.
- Board committees met 15 times in aggregate, and each director attended 100% of the meetings of the committees on which they served.
- The Audit Committee met four times, the Compensation Committee five times, and the Nominations and Corporate Governance Committee six times.
Guidance, Risks, Contingencies, and Unusual Items
The filing contains no management guidance, outlook, risk updates, contingencies, or unusual financial items. The Item 8.01 information is furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Confirm the fiscal-year period covered: year ended June 30, 2021.
- Verify board and committee attendance disclosures against the company’s proxy statement or other governance filings.
- Review subsequent filings for financial results, liquidity, financing activity, product developments, and updated risk factors, none of which are addressed here.